References
-
1) Frequency cumulative effect of subthreshold energy laser-activated remote phosphors irradiation on visual function in guinea pigs.
Product: GNAT1 Antibody (#DF4109)Year: 2022Journal: INT J OPHTHALMOL-CHIImpactFactor: 1.9DOI: 10.18240/ijo.2022.02.04PMID: 35186679 -
2) Long Mu Qing Xin mixture improves behavioral performance in spontaneously hypertensive rats (SHR/NCrl) by upregulating catecholamine neurotransmitters in prefrontal cortex and striatum via DRD1/cAMP/PKA-CREB signaling pathway.
Product: GNAL Antibody (#DF4108)Year: 2024Journal: Front PharmacolImpactFactor: 5.6DOI: 10.3389/fphar.2024.1387359PMID: 39027341 -
3) Kaempferol alleviates calcium oxalate crystal-induced renal injury and crystal deposition via regulation of the AR/NOX2 signaling pathway.
Product: ENTPD1/CD39 Antibody (#DF4031)Year: 2021Journal: PHYTOMEDICINEImpactFactor: 6.7DOI: 10.1016/j.phymed.2021.153555PMID: 33852977 -
4) A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with 68Ga-labeled PD-L1 targeted nanobody.
Product: ENTPD1/CD39 Antibody (#DF4031)Year: 2021Journal: AGING-USImpactFactor: 3.9DOI: 10.18632/aging.202981PMID: 33910164 -
5) Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.
Product: RNF138 Antibody (#DF4025)Year: 2018Journal: ONCOL REPImpactFactor: 3.8DOI: 10.3892/or.2018.6744PMID: 30272353 -
6) Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway.
Product: PSD93 Antibody (#DF3995)Year: 2023Journal: Int J Biol SciImpactFactor: 8.2DOI: 10.7150/ijbs.83264PMID: 37416779 -
7) GSK-3β inhibition alleviates arthritis pain via reducing spinal mitochondrial reactive oxygen species level and inflammation.
Product: DHODH Antibody (#DF3991)Year: 2023Journal: PLoS OneImpactFactor: 2.9DOI: 10.1371/journal.pone.0284332PMID: 37058473 -
8) Identification of Molecular Correlations Between DHRS4 and Progressive Neurodegeneration in Amyotrophic Lateral Sclerosis By Gene Co-Expression Network Analysis.
Product: DHRS4 Antibody (#DF3986)Year: 2022Journal: Front. Immunol.ImpactFactor: 5.7DOI: 10.3389/fimmu.2022.874978PMID: 35479082 -
9) One potential biomarker for teratozoospermia identified by in-depth integrative analysis of multiple microarray data.
Product: AGBL4 Antibody (#DF3981)Year: 2021Journal: AGING-USImpactFactor: 3.9DOI: 10.18632/aging.202781PMID: 33819193 -
10) Targeted inhibition of autophagy in hepatic stellate cells by hydroxychloroquine: An effective therapeutic approach for the treatment of liver fibrosis.
Product: ATG4D Antibody (#DF3977)Year: 2024Journal: Liver IntImpactFactor: 6DOI: 10.1111/liv.15915PMID: 38606676 -
11) Pathogenic variants of ATG4D in infertile men with non‐obstructive azoospermia identified using whole‐exome sequencing.
Product: ATG4D Antibody (#DF3977)Year: 2021Journal: CLIN GENETImpactFactor: 2.9DOI: 10.1111/cge.13995PMID: 33988247 -
12) Horse-Derived Ceramide Accentuates Glucosylceramide Synthase and Ceramide Synthase 3 by Activating PPARβ/δ and/or PPARγ to Stimulate Ceramide Synthesis.
Product: ELOVL4 Antibody (#DF4037)Year: 2023Journal: BiomedicinesImpactFactor: 4.7DOI: 10.3390/biomedicines11020548PMID: 36831084 -
13) Sp1 participates in the cadmium-induced imbalance of the placental glucocorticoid barrier by suppressing 11β-HSD2 expression.
Product: HSD11B1 Antibody (#DF3972)Year: 2020Journal: ENVIRON POLLUTImpactFactor: 7.6DOI: 10.1016/j.envpol.2020.113976PMID: 32044612 -
14) Metformin-based carbon dots based on biguanide functional groups for simultaneous chelation of copper ions and inhibitable colorectal cancer therapy.
Product: CCS/SOD4 Antibody (#DF3971)Year: 2023Journal: CARBONImpactFactor: 10.5DOI: 10.1016/j.carbon.2023.118095 -
15) Inhibition of ASIC1a-Mediated ERS Improves the Activation of HSCs and Copper Transport Under Copper Load.
Product: CCS/SOD4 Antibody (#DF3971)Year: 2021Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2021.653272PMID: 34135753